Table of Content

1 Metformin Hydrochloride Sustained-release Drug Market Overview
1.1 Product Overview and Scope of Metformin Hydrochloride Sustained-release Drug
1.2 Metformin Hydrochloride Sustained-release Drug Segment by Type
1.2.1 Global Metformin Hydrochloride Sustained-release Drug Market Value Comparison by Type (2024-2034)
1.2.2 Tablet
1.2.3 Capsule
1.3 Metformin Hydrochloride Sustained-release Drug Segment by Application
1.3.1 Global Metformin Hydrochloride Sustained-release Drug Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Metformin Hydrochloride Sustained-release Drug Market Size Estimates and Forecasts
1.4.1 Global Metformin Hydrochloride Sustained-release Drug Revenue 2024-2034
1.4.2 Global Metformin Hydrochloride Sustained-release Drug Sales 2024-2034
1.4.3 Global Metformin Hydrochloride Sustained-release Drug Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Metformin Hydrochloride Sustained-release Drug Market Competition by Manufacturers
2.1 Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Manufacturers (2024-2024)
2.2 Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Metformin Hydrochloride Sustained-release Drug Average Price by Manufacturers (2024-2024)
2.4 Global Metformin Hydrochloride Sustained-release Drug Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Metformin Hydrochloride Sustained-release Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Metformin Hydrochloride Sustained-release Drug, Product Type & Application
2.7 Metformin Hydrochloride Sustained-release Drug Market Competitive Situation and Trends
2.7.1 Metformin Hydrochloride Sustained-release Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Metformin Hydrochloride Sustained-release Drug Players Market Share by Revenue
2.7.3 Global Metformin Hydrochloride Sustained-release Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Metformin Hydrochloride Sustained-release Drug Retrospective Market Scenario by Region
3.1 Global Metformin Hydrochloride Sustained-release Drug Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Metformin Hydrochloride Sustained-release Drug Global Metformin Hydrochloride Sustained-release Drug Sales by Region: 2024-2034
3.2.1 Global Metformin Hydrochloride Sustained-release Drug Sales by Region: 2024-2024
3.2.2 Global Metformin Hydrochloride Sustained-release Drug Sales by Region: 2024-2034
3.3 Global Metformin Hydrochloride Sustained-release Drug Global Metformin Hydrochloride Sustained-release Drug Revenue by Region: 2024-2034
3.3.1 Global Metformin Hydrochloride Sustained-release Drug Revenue by Region: 2024-2024
3.3.2 Global Metformin Hydrochloride Sustained-release Drug Revenue by Region: 2024-2034
3.4 North America Metformin Hydrochloride Sustained-release Drug Market Facts & Figures by Country
3.4.1 North America Metformin Hydrochloride Sustained-release Drug Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Metformin Hydrochloride Sustained-release Drug Sales by Country (2024-2034)
3.4.3 North America Metformin Hydrochloride Sustained-release Drug Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Metformin Hydrochloride Sustained-release Drug Market Facts & Figures by Country
3.5.1 Europe Metformin Hydrochloride Sustained-release Drug Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Metformin Hydrochloride Sustained-release Drug Sales by Country (2024-2034)
3.5.3 Europe Metformin Hydrochloride Sustained-release Drug Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Metformin Hydrochloride Sustained-release Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Metformin Hydrochloride Sustained-release Drug Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Metformin Hydrochloride Sustained-release Drug Sales by Country (2024-2034)
3.6.3 Asia Pacific Metformin Hydrochloride Sustained-release Drug Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Metformin Hydrochloride Sustained-release Drug Market Facts & Figures by Country
3.7.1 Latin America Metformin Hydrochloride Sustained-release Drug Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Metformin Hydrochloride Sustained-release Drug Sales by Country (2024-2034)
3.7.3 Latin America Metformin Hydrochloride Sustained-release Drug Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Metformin Hydrochloride Sustained-release Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Metformin Hydrochloride Sustained-release Drug Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Metformin Hydrochloride Sustained-release Drug Sales by Country (2024-2034)
3.8.3 Middle East and Africa Metformin Hydrochloride Sustained-release Drug Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Metformin Hydrochloride Sustained-release Drug Sales by Type (2024-2034)
4.1.1 Global Metformin Hydrochloride Sustained-release Drug Sales by Type (2024-2024)
4.1.2 Global Metformin Hydrochloride Sustained-release Drug Sales by Type (2024-2034)
4.1.3 Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Type (2024-2034)
4.2 Global Metformin Hydrochloride Sustained-release Drug Revenue by Type (2024-2034)
4.2.1 Global Metformin Hydrochloride Sustained-release Drug Revenue by Type (2024-2024)
4.2.2 Global Metformin Hydrochloride Sustained-release Drug Revenue by Type (2024-2034)
4.2.3 Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Type (2024-2034)
4.3 Global Metformin Hydrochloride Sustained-release Drug Price by Type (2024-2034)
5 Segment by Application
5.1 Global Metformin Hydrochloride Sustained-release Drug Sales by Application (2024-2034)
5.1.1 Global Metformin Hydrochloride Sustained-release Drug Sales by Application (2024-2024)
5.1.2 Global Metformin Hydrochloride Sustained-release Drug Sales by Application (2024-2034)
5.1.3 Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Application (2024-2034)
5.2 Global Metformin Hydrochloride Sustained-release Drug Revenue by Application (2024-2034)
5.2.1 Global Metformin Hydrochloride Sustained-release Drug Revenue by Application (2024-2024)
5.2.2 Global Metformin Hydrochloride Sustained-release Drug Revenue by Application (2024-2034)
5.2.3 Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Application (2024-2034)
5.3 Global Metformin Hydrochloride Sustained-release Drug Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Merck Metformin Hydrochloride Sustained-release Drug Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Viatris
6.2.1 Viatris Corporation Information
6.2.2 Viatris Description and Business Overview
6.2.3 Viatris Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Viatris Metformin Hydrochloride Sustained-release Drug Product Portfolio
6.2.5 Viatris Recent Developments/Updates
6.3 Apotex
6.3.1 Apotex Corporation Information
6.3.2 Apotex Description and Business Overview
6.3.3 Apotex Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Apotex Metformin Hydrochloride Sustained-release Drug Product Portfolio
6.3.5 Apotex Recent Developments/Updates
6.4 Teva Pharmaceuticals
6.4.1 Teva Pharmaceuticals Corporation Information
6.4.2 Teva Pharmaceuticals Description and Business Overview
6.4.3 Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product Portfolio
6.4.5 Teva Pharmaceuticals Recent Developments/Updates
6.5 Sun Pharmaceutical Industries
6.5.1 Sun Pharmaceutical Industries Corporation Information
6.5.2 Sun Pharmaceutical Industries Description and Business Overview
6.5.3 Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Product Portfolio
6.5.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.6 Dr. Reddy's Laboratories
6.6.1 Dr. Reddy's Laboratories Corporation Information
6.6.2 Dr. Reddy's Laboratories Description and Business Overview
6.6.3 Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Product Portfolio
6.6.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.7 CSPC
6.6.1 CSPC Corporation Information
6.6.2 CSPC Description and Business Overview
6.6.3 CSPC Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2024-2024)
6.4.4 CSPC Metformin Hydrochloride Sustained-release Drug Product Portfolio
6.7.5 CSPC Recent Developments/Updates
6.8 Jingfeng Pharmaceutical Group
6.8.1 Jingfeng Pharmaceutical Group Corporation Information
6.8.2 Jingfeng Pharmaceutical Group Description and Business Overview
6.8.3 Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Product Portfolio
6.8.5 Jingfeng Pharmaceutical Group Recent Developments/Updates
6.9 Topfond Pharmaceutical
6.9.1 Topfond Pharmaceutical Corporation Information
6.9.2 Topfond Pharmaceutical Description and Business Overview
6.9.3 Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio
6.9.5 Topfond Pharmaceutical Recent Developments/Updates
6.10 SinocorpPharma
6.10.1 SinocorpPharma Corporation Information
6.10.2 SinocorpPharma Description and Business Overview
6.10.3 SinocorpPharma Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2024-2024)
6.10.4 SinocorpPharma Metformin Hydrochloride Sustained-release Drug Product Portfolio
6.10.5 SinocorpPharma Recent Developments/Updates
6.11 CTTQ
6.11.1 CTTQ Corporation Information
6.11.2 CTTQ Metformin Hydrochloride Sustained-release Drug Description and Business Overview
6.11.3 CTTQ Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2024-2024)
6.11.4 CTTQ Metformin Hydrochloride Sustained-release Drug Product Portfolio
6.11.5 CTTQ Recent Developments/Updates
6.12 Shanghai Pharmaceuticals
6.12.1 Shanghai Pharmaceuticals Corporation Information
6.12.2 Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Description and Business Overview
6.12.3 Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product Portfolio
6.12.5 Shanghai Pharmaceuticals Recent Developments/Updates
6.13 Tianan Pharmaceutical
6.13.1 Tianan Pharmaceutical Corporation Information
6.13.2 Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Description and Business Overview
6.13.3 Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio
6.13.5 Tianan Pharmaceutical Recent Developments/Updates
6.14 Qingdao Huanghai Pharmaceutical
6.14.1 Qingdao Huanghai Pharmaceutical Corporation Information
6.14.2 Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Description and Business Overview
6.14.3 Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio
6.14.5 Qingdao Huanghai Pharmaceutical Recent Developments/Updates
6.15 Chongqing Conquer Pharmaceutical
6.15.1 Chongqing Conquer Pharmaceutical Corporation Information
6.15.2 Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Description and Business Overview
6.15.3 Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio
6.15.5 Chongqing Conquer Pharmaceutical Recent Developments/Updates
6.16 Jiangsu Deyuan Pharmaceutical
6.16.1 Jiangsu Deyuan Pharmaceutical Corporation Information
6.16.2 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Description and Business Overview
6.16.3 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio
6.16.5 Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
6.17 Beijing Shengyong Pharmaceutical
6.17.1 Beijing Shengyong Pharmaceutical Corporation Information
6.17.2 Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Description and Business Overview
6.17.3 Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales, Revenue and Gross Margin (2024-2024)
6.17.4 Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product Portfolio
6.17.5 Beijing Shengyong Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Metformin Hydrochloride Sustained-release Drug Industry Chain Analysis
7.2 Metformin Hydrochloride Sustained-release Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Metformin Hydrochloride Sustained-release Drug Production Mode & Process
7.4 Metformin Hydrochloride Sustained-release Drug Sales and Marketing
7.4.1 Metformin Hydrochloride Sustained-release Drug Sales Channels
7.4.2 Metformin Hydrochloride Sustained-release Drug Distributors
7.5 Metformin Hydrochloride Sustained-release Drug Customers
8 Metformin Hydrochloride Sustained-release Drug Market Dynamics
8.1 Metformin Hydrochloride Sustained-release Drug Industry Trends
8.2 Metformin Hydrochloride Sustained-release Drug Market Drivers
8.3 Metformin Hydrochloride Sustained-release Drug Market Challenges
8.4 Metformin Hydrochloride Sustained-release Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Metformin Hydrochloride Sustained-release Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Metformin Hydrochloride Sustained-release Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Metformin Hydrochloride Sustained-release Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Metformin Hydrochloride Sustained-release Drug Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Metformin Hydrochloride Sustained-release Drug Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Metformin Hydrochloride Sustained-release Drug Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Metformin Hydrochloride Sustained-release Drug Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Metformin Hydrochloride Sustained-release Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Metformin Hydrochloride Sustained-release Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Metformin Hydrochloride Sustained-release Drug, Product Type & Application
Table 12. Global Key Manufacturers of Metformin Hydrochloride Sustained-release Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Metformin Hydrochloride Sustained-release Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metformin Hydrochloride Sustained-release Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Metformin Hydrochloride Sustained-release Drug Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Metformin Hydrochloride Sustained-release Drug Sales by Region (2024-2024) & (K Units)
Table 18. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Region (2024-2024)
Table 19. Global Metformin Hydrochloride Sustained-release Drug Sales by Region (2024-2034) & (K Units)
Table 20. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Region (2024-2034)
Table 21. Global Metformin Hydrochloride Sustained-release Drug Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Region (2024-2024)
Table 23. Global Metformin Hydrochloride Sustained-release Drug Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Region (2024-2034)
Table 25. North America Metformin Hydrochloride Sustained-release Drug Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Metformin Hydrochloride Sustained-release Drug Sales by Country (2024-2024) & (K Units)
Table 27. North America Metformin Hydrochloride Sustained-release Drug Sales by Country (2024-2034) & (K Units)
Table 28. North America Metformin Hydrochloride Sustained-release Drug Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Metformin Hydrochloride Sustained-release Drug Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Metformin Hydrochloride Sustained-release Drug Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Metformin Hydrochloride Sustained-release Drug Sales by Country (2024-2024) & (K Units)
Table 32. Europe Metformin Hydrochloride Sustained-release Drug Sales by Country (2024-2034) & (K Units)
Table 33. Europe Metformin Hydrochloride Sustained-release Drug Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Metformin Hydrochloride Sustained-release Drug Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Metformin Hydrochloride Sustained-release Drug Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Metformin Hydrochloride Sustained-release Drug Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Metformin Hydrochloride Sustained-release Drug Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Metformin Hydrochloride Sustained-release Drug Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Metformin Hydrochloride Sustained-release Drug Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Metformin Hydrochloride Sustained-release Drug Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Metformin Hydrochloride Sustained-release Drug Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Metformin Hydrochloride Sustained-release Drug Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Metformin Hydrochloride Sustained-release Drug Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Metformin Hydrochloride Sustained-release Drug Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Metformin Hydrochloride Sustained-release Drug Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Metformin Hydrochloride Sustained-release Drug Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Metformin Hydrochloride Sustained-release Drug Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Metformin Hydrochloride Sustained-release Drug Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Metformin Hydrochloride Sustained-release Drug Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Metformin Hydrochloride Sustained-release Drug Sales (K Units) by Type (2024-2024)
Table 51. Global Metformin Hydrochloride Sustained-release Drug Sales (K Units) by Type (2024-2034)
Table 52. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Type (2024-2024)
Table 53. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Type (2024-2034)
Table 54. Global Metformin Hydrochloride Sustained-release Drug Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Metformin Hydrochloride Sustained-release Drug Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Type (2024-2024)
Table 57. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Type (2024-2034)
Table 58. Global Metformin Hydrochloride Sustained-release Drug Price (US$/Unit) by Type (2024-2024)
Table 59. Global Metformin Hydrochloride Sustained-release Drug Price (US$/Unit) by Type (2024-2034)
Table 60. Global Metformin Hydrochloride Sustained-release Drug Sales (K Units) by Application (2024-2024)
Table 61. Global Metformin Hydrochloride Sustained-release Drug Sales (K Units) by Application (2024-2034)
Table 62. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Application (2024-2024)
Table 63. Global Metformin Hydrochloride Sustained-release Drug Sales Market Share by Application (2024-2034)
Table 64. Global Metformin Hydrochloride Sustained-release Drug Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Metformin Hydrochloride Sustained-release Drug Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Application (2024-2024)
Table 67. Global Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Application (2024-2034)
Table 68. Global Metformin Hydrochloride Sustained-release Drug Price (US$/Unit) by Application (2024-2024)
Table 69. Global Metformin Hydrochloride Sustained-release Drug Price (US$/Unit) by Application (2024-2034)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Metformin Hydrochloride Sustained-release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Merck Metformin Hydrochloride Sustained-release Drug Product
Table 74. Merck Recent Developments/Updates
Table 75. Viatris Corporation Information
Table 76. Viatris Description and Business Overview
Table 77. Viatris Metformin Hydrochloride Sustained-release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Viatris Metformin Hydrochloride Sustained-release Drug Product
Table 79. Viatris Recent Developments/Updates
Table 80. Apotex Corporation Information
Table 81. Apotex Description and Business Overview
Table 82. Apotex Metformin Hydrochloride Sustained-release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Apotex Metformin Hydrochloride Sustained-release Drug Product
Table 84. Apotex Recent Developments/Updates
Table 85. Teva Pharmaceuticals Corporation Information
Table 86. Teva Pharmaceuticals Description and Business Overview
Table 87. Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product
Table 89. Teva Pharmaceuticals Recent Developments/Updates
Table 90. Sun Pharmaceutical Industries Corporation Information
Table 91. Sun Pharmaceutical Industries Description and Business Overview
Table 92. Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Product
Table 94. Sun Pharmaceutical Industries Recent Developments/Updates
Table 95. Dr. Reddy's Laboratories Corporation Information
Table 96. Dr. Reddy's Laboratories Description and Business Overview
Table 97. Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Product
Table 99. Dr. Reddy's Laboratories Recent Developments/Updates
Table 100. CSPC Corporation Information
Table 101. CSPC Description and Business Overview
Table 102. CSPC Metformin Hydrochloride Sustained-release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. CSPC Metformin Hydrochloride Sustained-release Drug Product
Table 104. CSPC Recent Developments/Updates
Table 105. Jingfeng Pharmaceutical Group Corporation Information
Table 106. Jingfeng Pharmaceutical Group Description and Business Overview
Table 107. Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Product
Table 109. Jingfeng Pharmaceutical Group Recent Developments/Updates
Table 110. Topfond Pharmaceutical Corporation Information
Table 111. Topfond Pharmaceutical Description and Business Overview
Table 112. Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product
Table 114. Topfond Pharmaceutical Recent Developments/Updates
Table 115. SinocorpPharma Corporation Information
Table 116. SinocorpPharma Description and Business Overview
Table 117. SinocorpPharma Metformin Hydrochloride Sustained-release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. SinocorpPharma Metformin Hydrochloride Sustained-release Drug Product
Table 119. SinocorpPharma Recent Developments/Updates
Table 120. CTTQ Corporation Information
Table 121. CTTQ Description and Business Overview
Table 122. CTTQ Metformin Hydrochloride Sustained-release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. CTTQ Metformin Hydrochloride Sustained-release Drug Product
Table 124. CTTQ Recent Developments/Updates
Table 125. Shanghai Pharmaceuticals Corporation Information
Table 126. Shanghai Pharmaceuticals Description and Business Overview
Table 127. Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product
Table 129. Shanghai Pharmaceuticals Recent Developments/Updates
Table 130. Tianan Pharmaceutical Corporation Information
Table 131. Tianan Pharmaceutical Description and Business Overview
Table 132. Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product
Table 134. Tianan Pharmaceutical Recent Developments/Updates
Table 135. Qingdao Huanghai Pharmaceutical Corporation Information
Table 136. Qingdao Huanghai Pharmaceutical Description and Business Overview
Table 137. Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product
Table 139. Qingdao Huanghai Pharmaceutical Recent Developments/Updates
Table 140. Chongqing Conquer Pharmaceutical Corporation Information
Table 141. Chongqing Conquer Pharmaceutical Description and Business Overview
Table 142. Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product
Table 144. Chongqing Conquer Pharmaceutical Recent Developments/Updates
Table 145. Jiangsu Deyuan Pharmaceutical Corporation Information
Table 146. Jiangsu Deyuan Pharmaceutical Description and Business Overview
Table 147. Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product
Table 149. Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
Table 150. Beijing Shengyong Pharmaceutical Corporation Information
Table 151. Beijing Shengyong Pharmaceutical Description and Business Overview
Table 152. Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product
Table 154. Beijing Shengyong Pharmaceutical Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Metformin Hydrochloride Sustained-release Drug Distributors List
Table 158. Metformin Hydrochloride Sustained-release Drug Customers List
Table 159. Metformin Hydrochloride Sustained-release Drug Market Trends
Table 160. Metformin Hydrochloride Sustained-release Drug Market Drivers
Table 161. Metformin Hydrochloride Sustained-release Drug Market Challenges
Table 162. Metformin Hydrochloride Sustained-release Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Metformin Hydrochloride Sustained-release Drug
Figure 2. Global Metformin Hydrochloride Sustained-release Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Metformin Hydrochloride Sustained-release Drug Market Share by Type in 2022 & 2034
Figure 4. Tablet Product Picture
Figure 5. Capsule Product Picture
Figure 6. Global Metformin Hydrochloride Sustained-release Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Metformin Hydrochloride Sustained-release Drug Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Metformin Hydrochloride Sustained-release Drug Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 12. Global Metformin Hydrochloride Sustained-release Drug Market Size (2024-2034) & (US$ Million)
Figure 13. Global Metformin Hydrochloride Sustained-release Drug Sales (2024-2034) & (K Units)
Figure 14. Global Metformin Hydrochloride Sustained-release Drug Average Price (US$/Unit) & (2024-2034)
Figure 15. Metformin Hydrochloride Sustained-release Drug Report Years Considered
Figure 16. Metformin Hydrochloride Sustained-release Drug Sales Share by Manufacturers in 2022
Figure 17. Global Metformin Hydrochloride Sustained-release Drug Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Metformin Hydrochloride Sustained-release Drug Players: Market Share by Revenue in 2022
Figure 19. Metformin Hydrochloride Sustained-release Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 20. Global Metformin Hydrochloride Sustained-release Drug Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 21. North America Metformin Hydrochloride Sustained-release Drug Sales Market Share by Country (2024-2034)
Figure 22. North America Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Country (2024-2034)
Figure 23. United States Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 24. Canada Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 25. Europe Metformin Hydrochloride Sustained-release Drug Sales Market Share by Country (2024-2034)
Figure 26. Europe Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Country (2024-2034)
Figure 27. Germany Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. France Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. U.K. Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. Italy Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Russia Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Asia Pacific Metformin Hydrochloride Sustained-release Drug Sales Market Share by Region (2024-2034)
Figure 33. Asia Pacific Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Region (2024-2034)
Figure 34. China Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Japan Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. South Korea Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. India Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Australia Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. China Taiwan Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Southeast Asia Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Latin America Metformin Hydrochloride Sustained-release Drug Sales Market Share by Country (2024-2034)
Figure 42. Latin America Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Country (2024-2034)
Figure 43. Mexico Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Brazil Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Argentina Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Middle East & Africa Metformin Hydrochloride Sustained-release Drug Sales Market Share by Country (2024-2034)
Figure 47. Middle East & Africa Metformin Hydrochloride Sustained-release Drug Revenue Market Share by Country (2024-2034)
Figure 48. Turkey Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Saudi Arabia Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. UAE Metformin Hydrochloride Sustained-release Drug Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. Global Sales Market Share of Metformin Hydrochloride Sustained-release Drug by Type (2024-2034)
Figure 52. Global Revenue Market Share of Metformin Hydrochloride Sustained-release Drug by Type (2024-2034)
Figure 53. Global Metformin Hydrochloride Sustained-release Drug Price (US$/Unit) by Type (2024-2034)
Figure 54. Global Sales Market Share of Metformin Hydrochloride Sustained-release Drug by Application (2024-2034)
Figure 55. Global Revenue Market Share of Metformin Hydrochloride Sustained-release Drug by Application (2024-2034)
Figure 56. Global Metformin Hydrochloride Sustained-release Drug Price (US$/Unit) by Application (2024-2034)
Figure 57. Metformin Hydrochloride Sustained-release Drug Value Chain
Figure 58. Metformin Hydrochloride Sustained-release Drug Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed